We are live on
!
Find out more
Canada Life Portfolio holdings
AUM
$55.8B
1-Year Est. Return
26.04%
This Fund
S&P 500
This Quarter
Est. Return
+7.79%
1 Year Est. Return
+26.04%
3 Year Est. Return
+87.85%
5 Year Est. Return
+117.08%
10 Year Est. Return
+382.61%
AUM
$46B
AUM Growth
+$3.76B
(+8.9%)
Cap. Flow
+$1.31B
Cap. Flow
% of AUM
2.85%
Top 10 Holdings %
Top 10 Hldgs %
15.96%
Holding
2,794
New
1,683
Increased
565
Reduced
451
Closed
36
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$82M |
| 2 |
Manulife Financial
MFC
|
+$61.4M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$50.1M |
| 4 |
Visa
V
|
+$49.7M |
| 5 |
Colgate-Palmolive
CL
|
+$48.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$167M |
| 2 |
Johnson Controls International
JCI
|
+$138M |
| 3 |
Johnson & Johnson
JNJ
|
+$113M |
| 4 |
Steris
STE
|
+$95.7M |
| 5 |
CELG
Celgene Corp
CELG
|
+$71.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21% |
| 2 | Technology | 16.36% |
| 3 | Healthcare | 10.14% |
| 4 | Consumer Discretionary | 9.18% |
| 5 | Communication Services | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FOLD
1951
DELISTED
Amicus Therapeutics
FOLD
| $175K | ﹤0.01% |
18,086
+4,450
| +33% | +$40.7K |
|
1952
Liquidity Services
LQDT
$1.32B
| $175K | ﹤0.01% |
29,652
| – | – |
|
1953
Amcor
AMCR
$22.1B
| $174K | ﹤0.01% |
3,215
-44,775
| -93% | -$2.24M |
|
|
ACRE
1954
Ares Commercial Real Estate
ACRE
$270M
| $171K | ﹤0.01% |
10,920
+9,749
| +833% | +$151K |
|
1955
Eldorado Gold
EGO
$9.89B
| $171K | ﹤0.01% |
21,334
+3,558
| +20% | +$27.6K |
|
|
TMHC
1956
DELISTED
Taylor Morrison
TMHC
| $171K | ﹤0.01% |
+7,857
| New | +$189K |
|
|
AKRX
1957
DELISTED
Akorn Inc
AKRX
| $171K | ﹤0.01% |
+115,736
| New | +$437K |
|
1958
Barings BDC
BBDC
$965M
| $169K | ﹤0.01% |
+16,581
| New | +$170K |
|
1959
Ring Energy
REI
$339M
| $169K | ﹤0.01% |
+65,007
| New | +$128K |
|
1960
Willis Towers Watson
WTW
$32B
| $168K | ﹤0.01% |
841
-109,771
| -99% | -$21M |
|
|
CLDR
1961
DELISTED
Cloudera, Inc.
CLDR
| $168K | ﹤0.01% |
+14,560
| New | +$139K |
|
1962
Houlihan Lokey
HLI
$9.02B
| $167K | ﹤0.01% |
+3,440
| New | +$162K |
|
|
SCS
1963
DELISTED
Steelcase
SCS
| $167K | ﹤0.01% |
+8,229
| New | +$153K |
|
|
WCC
1964
WESCO International
WCC
$17.7B
| $167K | ﹤0.01% |
+2,830
| New | +$148K |
|
1965
Newmark Group
NMRK
$2.63B
| $166K | ﹤0.01% |
+12,419
| New | +$145K |
|
1966
PTC Therapeutics
PTCT
$6.12B
| $166K | ﹤0.01% |
+3,493
| New | +$148K |
|
1967
Axsome Therapeutics
AXSM
$10.9B
| $165K | ﹤0.01% |
+1,610
| New | +$65K |
|
|
XLRN
1968
DELISTED
Acceleron Pharma
XLRN
| $164K | ﹤0.01% |
+3,114
| New | +$142K |
|
1969
BGC Group
BGC
$4.89B
| $163K | ﹤0.01% |
+27,805
| New | +$157K |
|
1970
Enphase Energy
ENPH
$5.53B
| $163K | ﹤0.01% |
+6,295
| New | +$143K |
|
1971
OR Royalties Inc
OR
$6.2B
| $163K | ﹤0.01% |
16,912
+1,855
| +12% | +$16.9K |
|
|
APHA
1972
DELISTED
Aphria Inc. Common Shares
APHA
| $160K | ﹤0.01% |
31,056
+26
| +0.1% | +$128 |
|
1973
Moelis & Co
MC
$4.94B
| $159K | ﹤0.01% |
+5,011
| New | +$164K |
|
1974
Ultragenyx Pharmaceutical
RARE
$2.55B
| $159K | ﹤0.01% |
+3,759
| New | +$155K |
|
1975
Simply Good Foods
SMPL
$982M
| $159K | ﹤0.01% |
+5,623
| New | +$148K |
|
Similar funds
Canada Life's Q4 2019 Portfolio in Review
As of Q4 2019, Canada Life held 2,794 positions worth $46B, up 8.9% from $42.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Canada Life's Q4 2019 filing shows 1,683 new, 565 increased, 451 reduced and 36 closed positions. Its largest new stake was Berkshire Hathaway Class A: 88 shares worth $29.7M. The largest sale was Apple, an estimated $167M.
By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 21% a quarter earlier, followed by Technology and Healthcare.
- Canada Life's largest Q4 2019 buy was Berkshire Hathaway Class A: 88 shares worth $29.7M.
- Canada Life added most to Alibaba in Q4 2019, an estimated $82M increase.
- Canada Life's biggest Q4 2019 reduction was Apple, cutting an estimated $167M.
- Canada Life fully exited Celgene Corp in Q4 2019, selling an estimated $71.4M.
- Canada Life's ten largest holdings make up 16% of its $46B portfolio in Q4 2019.
- Canada Life opened 1,683 new positions and closed 36 in Q4 2019.
- Canada Life's portfolio value rose 8.9% quarter-over-quarter to $46B.
Based on Canada Life's 13F filing for Q4 2019, filed 11 Feb 2020.